Literature DB >> 597250

Studies on C3 convertases. Inhibition of C5 convertase formation by peptides containing aromatic amino acids.

A Kossorotow, W Opitz, E Etschenberg, U Hadding.   

Abstract

The influence of various peptides containing the aromatic amino acids phenylalanine and tyrosine on the formation of the enzyme EAC1423 of the complement system from component C3 and enzyme EAC142 was investigated. Kinetic analysis of enzyme EAC1423 formation and studies on the binding of the C3b fragment of 125I-labelled component C3 to enzyme EAC142 both showed that binding of the C3b fragment of component C3 was decreased by the peptides. Kinetic studies on component-C3 turnover in the fluid phase of enzyme EAC142 failed to reveal effects of the peptides. However, an initial lag in component-C3 turnover occurred that at constant component-C3 concentration was inversely proportional to enzyme EAC142 concentration. This lag in enzyme EAC142 activity is considered as an indication that the interaction of enzyme EAC142 with component C3 possibly does not follow simple Michaelis-Menten kinetics, as was previously assumed. It is shown that the stages after enzyme EAC1423 formation are not influenced by the peptides, suggesting a high degree of specificity of the peptides for the inhibition of enzyme EAC1423 formation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 597250      PMCID: PMC1183668          DOI: 10.1042/bj1670377

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  12 in total

Review 1.  Complement.

Authors:  H J Müller-Eberhard
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

2.  Transients and cooperativity. A slow transition model for relating transients and cooperative kinetics of enzymes.

Authors:  G R Ainslie; J P Shill; K E Neet
Journal:  J Biol Chem       Date:  1972-11-10       Impact factor: 5.157

3.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

4.  A slow transient kinetic process of yeast hexokinase.

Authors:  J P Shill; K E Neet
Journal:  Biochem J       Date:  1971-06       Impact factor: 3.857

5.  The third component of the guinea pig complement system. 3. Effect of inhibitors.

Authors:  H S Shin; M M Mayer
Journal:  Biochemistry       Date:  1968-08       Impact factor: 3.162

6.  Kinetic aspects of regulation of metabolic processes. The hysteretic enzyme concept.

Authors:  C Frieden
Journal:  J Biol Chem       Date:  1970-11-10       Impact factor: 5.157

7.  Independent and consecutive action of the complement components C5, C6 and C7 in immune hemolysis. I. Preparation of EAC1-5 with purified guinea pig C3 and C5.

Authors:  D Bitter-Suermann; U Hadding; F Melchert; H J Wellensiek
Journal:  Immunochemistry       Date:  1970-12

8.  Bypass-activation of the complement system starting with C3. I. Generation and function of an enzyme from a factor of guinea-pig serum and cobra venom.

Authors:  D Bitter-Suermann; M Dierich; W König; U Hadding
Journal:  Immunology       Date:  1972-09       Impact factor: 7.397

9.  Dextran sulphate: a synthetic activator of C3 via the alternative pathway. I. Influence of molecular size and degree of sulphation on the activation potency.

Authors:  R Burger; U Hadding; H U Schorlemmer; V Brade; D Bitter-Suermann
Journal:  Immunology       Date:  1975-09       Impact factor: 7.397

10.  Formation and function of a complex of the C3 proactivator with a protein from cobra venom.

Authors:  N R Cooper
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

View more
  1 in total

1.  Structure-function analysis of decay-accelerating factor: identification of residues important for binding of the Escherichia coli Dr adhesin and complement regulation.

Authors:  Rafia J Hasan; Edyta Pawelczyk; Petri T Urvil; Mathura S Venkatarajan; Pawel Goluszko; Jozef Kur; Rangaraj Selvarangan; Stella Nowicki; Werner A Braun; Bogdan J Nowicki
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.